District Court Rules that Oxycontin Class Allegations May Be Withdrawn
March 25, 2002
DOCUMENTS
- Decision
ABINGDON, Va. - According to a March 14 decision by the U.S. District Court for the Western District of Virginia, it is not necessary to determine class certification under Federal Rule of Civil Procedure 23 before allowing the plaintiffs to withdraw their class action allegations in the McCaulley v. Purdue Pharma OxyContin case. A.F. McCaulley, et al. v. Purdue Pharma, L.P., et al., No. 2:01CV00080 (D. Va.).
Determination under Rule 23 is unnecessary in this particular case because, in spite of the wide publicity over the case, there has been no direct showing of any reliance by putative class members, …
UPCOMING CONFERENCES
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo
HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates
May 29, 2024 - Salt Lake City, UT
The Grand America Hotel